The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Intense research over the past four years has led to the discovery and characterization of a novel signalling network, known as the Salvador-Warts-Hippo (SWH) pathway, involved in tissue growth control in Drosophila melanogaster. At present, eleven proteins have been implicated as members of this pathway, and several downstream effector genes have been characterized. The importance of this pathway is emphasized by its evolutionary conservation, and by increasing evidence that its deregulation occurs in human tumours. Here, we review the main findings from Drosophila and the implications that these have for tumorigenesis in mammals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B., & Cohen, S. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00231-9 · Cited by 2,042
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
A Protein Interaction Map of Drosophila melanogaster
Giot, L., Bader, J. S., Brouwer, C., Chaudhuri, A., Kuang, B., Li, Y., Hao, Y. L., Ooi, C. E., Godwin, B., Vitols, E., et al. (2003) · Science · doi:10.1126/science.1090289 · Cited by 1,863 · cited 1×
“In unbiased protein–protein interaction screens in both Drosophila and mammals, YKI and YAP, and SD and TEF proteins were identified as binding partner”
BackgroundERM proteins and merlin: integrators at the cell cortex
Bretscher, A., Edwards, K., & Fehon, R. G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm882 · Cited by 1,306
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
Research works printed but not linked: 1
- Polesello, C., Huelsmann, S., Brown, N. H. & Tapon, N. The Drosophila RASSF homologue antagnosis the Hippo pathway. Curr. Biol. 16, 2459–2465 (2006). · DOI · Paper page
Cited by
Items 301–400 of 629
YAP1 Recruits c-Abl to Protect Angiomotin-Like 1 from Nedd4-Mediated Degradation
Skouloudaki, K., & Walz, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035735 · Cited by 41
Zhang, L., Ye, D., Pan, H., Wei, K., Wang, L., Wang, X.-D., Shen, G.-F., & Zhang, Z. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.06.003 · Cited by 42
Hirabayashi, S., & Cagan, R. L. (2015) · eLife · doi:10.7554/elife.08501 · Cited by 45
“The Hippo pathway is an evolutionarily conserved signaling pathway that regulates tissue growth and cell fate (Harvey and Tapon, 2007; Halder and Johnson, 2011).”
BackgroundSTK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism
Bae, S. J., Ni, L., & Luo, X. (2020) · eLife · doi:10.7554/elife.54863 · Cited by 45
“Introduction The Hippo pathway is critical for organ size control, tissue homeostasis, development, and tumor suppression by restricting cell proliferation and promoting apoptosis (Harvey and Tapon, 2007; Pan, 2010; Johnson and Halder, 2014; Yu et al., 2015; Fu et al., 2017; Misra and Irvine, 2018).”
BackgroundCrossroads of Wnt and Hippo in epithelial tissues
Bernascone, I., & Martín‐Belmonte, F. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.03.007 · Cited by 44
Hippo signaling controls cell cycle and restricts cell plasticity in planarians
de Sousa, N., Rodríguez-Esteban, G., Rojo-Laguna, J. I., Saló, E., & Adell, T. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2002399 · Cited by 41
Sun, H., Zhou, H., Zhang, Y., Chen, J., Han, X., Huang, D., Ren, X., Jia, Y.-H., Fan, Q., Tian, W., et al. (2018) · Journal of Cancer · doi:10.7150/jca.24797 · Cited by 40
“FAT4, which located at the apical point of the Hippo signaling pathway, controls the size of organs by modulating cell growth, proliferation, and apoptosis [8, 9].”
BackgroundOverexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression
Abali, G. K., Alptekin, A., & Cinar, B. (2014) · Epigenetics · doi:10.4161/epi.27957 · Cited by 44
Li, X. J., Park, E. S., Park, M. H., & Kim, S. M. (2013) · Oncology Reports · doi:10.3892/or.2013.2717 · Cited by 40
Mohamed, A. D., Sun, C., Mello, V. D., Selfe, J., Missiaglia, E., SHIPLEY, J. M., Murray, G. I., Zammit, P. S., & Wackerhage, H. (2016) · The Journal of Pathology · doi:10.1002/path.4745 · Cited by 50
“Yap and Taz are not only regulated by the Hippo pathway [3] but are also additionally targeted by a network of other signalling molecules, including PIK3CA [4], KRAS [5–7] and CTNNB1 (encoding β-catenin) [8].”
BackgroundNawaz, Z., Patil, V., Arora, A., Hegde, A. S., Arivazhagan, A., Santosh, V., & Somasundaram, K. (2016) · Scientific Reports · doi:10.1038/srep27753 · Cited by 42
Lyu, Z., Qin, N., Tyasi, T. L., Zhu, H., Liu, D., Yuan, S., & Xu, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160896 · Cited by 44
DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast
Huang, K. T., Dobrovic, A., Yan, M., Karim, R. Z., Lee, C. S., Lakhani, S. R., & Fox, S. B. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0970-4 · Cited by 39
“RASSF1A which interacts with mammalian sterile twenty (Hippo) kinases [26] has been found to be involved in cell cycle control [27, 28] and apoptotic signalling [29, 30].”
BackgroundGarcia, G., Wang, Y., Irudayam, J. I., Jeyachandran, A. V., Cario, S. C., Sen, C., Li, S., Li, Y., Kumar, A., Nielsen‐Saines, K., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001851 · Cited by 43
Proproliferative and antiapoptotic action of exogenously introduced YAP in pancreatic β cells
Yuan, T., Rafizadeh, S., Azizi, Z., Lupše, B., Gorrepati, K. D. D., Awal, S., Oberholzer, J., Maedler, K., & Ardestani, A. D. (2016) · JCI Insight · doi:10.1172/jci.insight.86326 · Cited by 43
“The loss of any component of the kinase core results in a YAP-dependent increase in proliferation and resistance to apoptosis in multiple tissues, suggesting Hippo as a powerful tool to regulate organ size (16–18).”
BackgroundClinical implications of the Hippo-YAP pathway in multiple cancer contexts
Kim, H., & Myung, S. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.018 · Cited by 39
“During the past decade, research on the biology and regulation of the Hippo pathway gained impetus from pioneering Drosophila studies (1-4).”
BackgroundZarrilli, G., Businello, G., Dieci, M. V., Paccagnella, S., Carraro, V., Cappellesso, R., Miglietta, F., Griguolo, G., Guarneri, V., Mele, M. L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218102 · Cited by 43
“YAP/TAZ can also cooperate with the transcription factors RUNX1/2, TBX5 and SMAD [100,102].”
BackgroundDevelopment of LM98, a Small‐Molecule TEAD Inhibitor Derived from Flufenamic Acid
Mélin, L., Abdullayev, S., Fnaiche, A., Vu, V., Suárez, N. G., Zeng, H., Szewczyk, M. M., Li, F., Senisterra, G. A., Allali‐Hassani, A., et al. (2021) · ChemMedChem · doi:10.1002/cmdc.202100432 · Cited by 41
Hippo Pathway in Regulating Drug Resistance of Glioblastoma
Casati, G., Giunti, L., Iorio, A. L., Marturano, A., Galli, L., & Sardi, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413431 · Cited by 51
The Hippo signal transduction pathway in soft tissue sarcomas
Mohamed, A. D., Tremblay, A., Murray, G. I., & Wackerhage, H. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.05.006 · Cited by 42
Luo, Z.-L., Luo, H., Chen, F., Cheng, L., Huang, Z., Dai, R., Li, K., Tian, F., Wang, T., & Tang, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6395 · Cited by 38
“Animals injected with Renilla shRNA harboring PANC-1 cells, showed predominant strong nuclear staining of YAP in metastatic lung tissue (Figure 3F).”
BackgroundInfluentialSuh, J. H., Won, K. Y., Kim, G. Y., Bae, G. E., Lim, S., Sung, J., Park, Y.-K., Kim, Y. W., & Lee, J. (2015) · PubMed Central · Cited by 37
Zhang, E., Shen, B., Mu, X., Qin, Y., Zhang, F., Liu, Y., Xiao, J., Zhang, P., Wang, C., Tan, M., et al. (2016) · PubMed · Cited by 47
RETRACTED: STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling
Tang, D., Dai, Y., Lin, L., Xu, Y. J., Liu, D., Hong, X., Jiang, H., & Xu, S. (2019) · Cancer Science · doi:10.1111/cas.14166 · Cited by 38
RetractedYuan, T., Annamalai, K., Naik, S., Lupše, B., Geravandi, S., Pal, A., Dobrowolski, A., Ghawali, J., Ruhlandt, M., Gorrepati, K. D. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25145-x · Cited by 42
Shimizu, T., Ho, L., & Lai, Z.-C. (2008) · Genetics · doi:10.1534/genetics.107.081570 · Cited by 46
“The Fat (Ft) protein may function as a receptor farther upstream or in parallel with Hpo/Wts signaling (Harvey and Tapon 2007; Pan 2007).”
BackgroundMethodYki/YAP, Sd/TEAD and Hth/MEIS Control Tissue Specification in the Drosophila Eye Disc Epithelium
Zhang, T., Zhou, Q., & Pignoni, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022278 · Cited by 39
“Conversely, the Hippo -Yorkie (Hpo-Yki) signaling pathway is known as a virtually universal regulator of proliferation and survival in both vertebrates and invertebrates (reviewed in [6–10]).”
Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A
Kay, L. J., Smulders-Srinivasan, T. K., & Soundararajan, M. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.07.001 · Cited by 42
Yorkie Regulates Neurodegeneration Through Canonical Pathway and Innate Immune Response
Dubey, S. K., & Tapadia, M. G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0388-7 · Cited by 40
“Having such diversity, interactions mediated through WW domains have been implicated in cancer [53, 54], in hereditary disorders, such as Liddle’s syndrome [55] and Rett’s syndrome [56], as well as in Alzheimer’s [57–59] and Huntington’s diseases [36, 60].”
BackgroundGu, Y., Wang, Y., Sha, Z., He, C., Zhu, Y., Li, J., Yu, A., Zhong, Z., Wang, X., Sun, Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111296 · Cited by 39
Lin, T.-H., Yeh, T.-H., Wang, T., & Yu, J. (2014) · Genetics · doi:10.1534/genetics.114.167346 · Cited by 48
WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
Chen, S., Wang, H., Huang, Y., Li, M., Cheng, J., Hu, P., Lu, C., Zhang, Y., Liu, N., Tzeng, C., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0693-9 · Cited by 38
“Emerging studies also show that Wnt signaling promotes breast cancer by blocking ITCH-mediated (an ubiquitin-conjugating enzyme) ubiquitin-dependent degradation of the YAP/TAZ transcriptional coactivator WBP2, suggesting WBP2/ITCH signaling functions to bridge the complex Wnt and Hippo signaling networks in breast can…”
BackgroundInfluentialSystematic analysis of the Hippo pathway organization and oncogenic alteration in evolution
Chen, Y., Han, H., Seo, G., Vargas, R. E., Yang, B., Chuc, K., Zhao, H., & Wang, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-60120-4 · Cited by 39
Effect of YAP1 silencing on esophageal cancer
Zhao, S., Zhao, J., Li, X., Yang, Y., Zhu, D., Zhang, C., Liu, D., & Wu, K. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s102338 · Cited by 37
“12,13 YAP1 as one component of the Hpo pathway in mammals is the ortholog of Yorkie (Yki) in Drosophila , which is the downstream effector of the Hpo pathway, and it negatively regulates the Hpo pathway.”
Li, C., Kan, L., Chen, Y., Zheng, X.-D., Li, W., Zhang, W., Cao, L., Lin, X., Ji, S., Huang, S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.114 · Cited by 37
Feng, D., Jia, X., Ye, F., & Wang, Y.-B. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.184499 · Cited by 34
“Human cancers have been linked to mutations in these genes (McClatchey and Giovannini, 2005; Harvey and Tapon, 2007).”
BackgroundYang, L., Li, X., Qin, X., Wang, Q., Zhou, K., Li, H., Zhang, X., Wang, Q., & Li, W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009559 · Cited by 34
“The Hippo-signaling pathway is a central regulator of organ size in a wide variety of animals, from Drosophila to mammals (4, 5).”
BackgroundMilton, C. C., Zhang, X., Albanese, N. O., & Harvey, K. F. (2010) · Development · doi:10.1242/dev.042309 · Cited by 37
“…for hpo, but not ft, ex or dco3 The SWH pathway controls eye size by regulating growth and proliferation rates throughout larval development by promoting cell cycle exit posterior to the morphogenetic furrow and promoting apoptosis at the mid-pupal stage of development (Harvey and Tapon, 2007).”
BackgroundSelf-citationHsiao, H., Jukam, D., Johnston, R. J., & Desplan, C. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.07.001 · Cited by 37
“(2013), http://dx.do Activation of the Hippo pathway leads to the phosphorylation of Warts that negatively regulates the Yorkie (Yki) oncogene (Harvey and Tapon, 2007; Huang et al., 2005).”
Madm (Mlf1 adapter molecule) cooperates with Bunched A to promote growth in Drosophila
Gluderer, S., Brunner, E., Germann, M., Jovaisaite, V., Li, C., Rentsch, C. A., Hafen, E., & Stocker, H. (2010) · Journal of Biology · doi:10.1186/jbiol216 · Cited by 33
“First, many tumor suppressor genes [25] and growth-regulating pathways [26,27] have been successfully studied in the fly.”
Kang, J., Shin, D.-H., Yu, J.-R., & Lee, J. (2009) · Development · doi:10.1242/dev.035485 · Cited by 38
“One well-known function of the Hpo pathway is to regulate cell growth and death, and maintain tissue-size homeostasis (Harvey and Tapon, 2007; Saucedo and Edgar, 2007).”
BackgroundYe, C., Wang, W., Xia, G., Yu, C., Yi, Y., Hua, C., Tu, F., Shen, L., Chen, C., Sun, W., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s196914 · Cited by 33
The emerging roles of WBP2 oncogene in human cancers
Tabatabaeian, H., Rao, A., Ramos, A., Chu, T., Sudol, M., & Lim, Y. P. (2020) · Oncogene · doi:10.1038/s41388-020-1318-0 · Cited by 34
Wang, Y., Zhu, Y., Gu, Y., Ma, M., Wang, Y., Qi, S., Zeng, Y. J., Zhu, R., Wang, X., Yu, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109596 · Cited by 34
Innovative Medicine: Basic Research and Development
Nakao, K., Minato, N., & Üemoto, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55651-0 · Cited by 10
The Hippo Size Control Pathway—Ever Expanding
Lin, J. I., Poon, C. L. C., & Harvey, K. F. (2013) · Science Signaling · doi:10.1126/scisignal.2003813 · Cited by 32
“What then regulates LRR1 activity or its ability to target PTPN14, and does LRR1 regulate PTPN14 abundance in vivo? Understanding the regulation of the Hippo pathway is important because this pathway is a key regulator of tissue growth during development and homeostasis, and loss of appropriate regulation can contribu…”
BackgroundSelf-citationHippo signaling: bridging the gap between cancer and neurodegenerative disorders
Singh, A., Gogia, N., Chimata, A. V., Deshpande, P., & Singh, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295273 · Cited by 32
“…gets its name, “Hippo” from the characteristic overgrowth phenotype of adult structures shown in the pathway component mutants (Justice et al., 1995; Xu et al., 1995; Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003; Kango-Singh and Singh, 2009).”
BackgroundLi, X. J., Leem, S., Park, M. H., & Kim, S. M. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2121 · Cited by 31
“Perturbation of this pathway has been shown to lead to an acceleration of tumorigenesis in mice (34) and loss of expression of the Hippo signaling pathway genes have been reported in a variety of cancers (33,35).”
BackgroundMei, L., Yuan, L., Shi, W., Fan, S., Tang, C., Fan, X., Yang, W., Qian, Y., Hussain, M., & Wu, X. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.009 · Cited by 31
Lee, H., Kang, J., Ahn, S., & Lee, J. (2019) · Genetics · doi:10.1534/genetics.119.302477 · Cited by 36
Malgundkar, S. H., Burney, I. A., Al-Moundhri, M. S., Kalbani, M. A., Lakhtakia, R., Okamoto, A., & Tamimi, Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-06900-7 · Cited by 32
From Rous sarcoma virus to plasminogen activator, src oncogene and cancer management
Sudol, M. (2011) · Oncogene · doi:10.1038/onc.2011.38 · Cited by 33
“Most recently, the YAP gene, whose cloning helped to identify the WW domain as a differentially spliced repeat of 38-amino-acid-long region (Bork and Sudol, 1994; Sudol, 1994), was shown to act as a bona fide oncogene and the main effector of the tumor suppressor pathway known as Hippo (Harvey and Tapon, 2007; Sudol a…”
BackgroundTAZ-Mediated Crosstalk between Wnt and Hippo Signaling
Hergovich, A., & Hemmings, B. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.04.003 · Cited by 29
“Over the past decade, Drosophila geneticists have successfully defined a tumor suppressor cascade controlling organ growth (Harvey and Tapon, 2007; Hergovich et al., 2006; Pan, 2007; Saucedo and Edgar, 2007).”
BackgroundBuffa, L., Saeed, A. M., & Nawaz, Z. (2012) · IUBMB Life · doi:10.1002/iub.1105 · Cited by 30
“Through a similar interaction, WBP-2 interacts with TAZ (transcriptional co-activator with PDZ-binding motif) a structurally and functionally similar protein to YAP and also a component of the Hippo pathway (27,28); with WW-domain containing oxidoreductase 1 (WWOX1), a protein that has been identified as a putative tu…”
BackgroundHippo andrassf1aPathways: A Growing Affair
Fausti, F., Agostino, S. D., Sacconi, A., Strano, S., & Blandino, G. (2012) · Molecular Biology International · doi:10.1155/2012/307628 · Cited by 37
“All of these components described above seem to be responsible for linking Hippo to extracellular stimuli [40].”
BackgroundNotch Inhibits Yorkie Activity in Drosophila Wing Discs
Djiane, A., Zaessinger, S., Babaoğlan, A. B., & Bray, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106211 · Cited by 31
“One of the best characterized Yki targets is the gene expanded (ex) [15].”
BackgroundStricker, T. P., & KUMAR, V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50012-2 · Cited by 60
Dalal, S., Connelly, B. A., Singh, M., & Singh, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196626 · Cited by 29
Targeting Hippo signaling pathway by phytochemicals in cancer therapy
Moloudizargari, M., Asghari, M. H., Nabavi, S. F., Gulei, D., Berindan‐Neagoe, I., Bishayee, A., & Nabavi, S. M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.005 · Cited by 29
Dvash, E., Kra‐Oz, G., Ziv, C., Carmeli, S., & Yarden, O. (2009) · Eukaryotic Cell · doi:10.1128/ec.00230-09 · Cited by 31
Hsu, T.-H., Yang, C.-Y., Yeh, T.-H., Huang, Y.-C., Wang, T., & Yu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04052-6 · Cited by 31
Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features
Marques, D., Ferreira-Costa, L. R., Ferreira-Costa, L. L., Corrêa, R. D. S., Borges, A. M. P., Ito, F. R., Ramos, C. C. D. O., Bortolin, R. H., Luchessi, A. D., Ribeiro‐dos‐Santos, Â., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6854 · Cited by 30
Nerfin-1 represses transcriptional output of Hippo signaling in cell competition
Guo, P., Lee, C.-H., Lei, H., Zheng, Y., Prieto, K. D. P., & Pan, D. (2019) · eLife · doi:10.7554/elife.38843 · Cited by 32
“The Hippo signaling pathway is a conserved mechanism that regulates organ size, tissue regeneration and stem cell biology in diverse animals (Halder and Johnson, 2011; Harvey and Tapon, 2007; Pan, 2010; Zhao et al., 2010).”
BackgroundDrosophila Model in Cancer: An Introduction
Chatterjee, D., & Deng, W. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-23629-8_1 · Cited by 29
Moleirinho, S., Calum, P., Tilston-Lünel, A., Higginson, J. R., Angus, L., Antkowiak, M. K., Barnett, S. C., Prystowsky, M. B., Reynolds, P. A., & Gunn, F. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060028 · Cited by 29
Pinosa, F., Begheldo, M., Pasternak, T. P., Zermiani, M., Paponov, I. A., Dovzhenko, A., Barcaccia, G., Ruperti, B., & Palme, K. J. (2013) · Annals of Botany · doi:10.1093/aob/mct235 · Cited by 26
“Mats is an orthologue of yeast Mob1 and has been involved in the Hpo signalling pathway, which participates in the control of tissue growth (reviewed by Hariharan and Bilder, 2006; Harvey and Tapon, 2007).”
BackgroundDeterminants of Cardiac Growth and Size
Heallen, T. R., Kadow, Z. A., Wang, J., & Martin, J. F. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037150 · Cited by 27
“IGF pathway activity is also stimulated in these hearts as a result of up-regulated levels of phosphoinositide 3-kinase (PI3K) and in- YAP LATS1/2 MST1/2 SAV1 APC Axin GSK3β β-Catenin β-Catenin Dsh Wnt IGFR PI3K P AKT Cardiomyocyte proliferation Cytoplasm Growth genes Nucleus IGFBP P TAZ YAP TEADs Tcf/Lef YAP P Advanc…”
BackgroundInfluentialYang, R., Kong, E., Jin, J., Hergovich, A., & Püschel, A. W. (2014) · Journal of Cell Science · doi:10.1242/jcs.146696 · Cited by 25
“The Lats/Warts kinases are central components of the Hippo signaling pathway, which controls cell growth and organ size by promoting cell death and differentiation and inhibiting proliferation (Harvey and Tapon, 2007; Pan, 2007; Yu and Guan, 2013; Zhao et al., 2011).”
BackgroundMutual Dependence of Mob1 and the Chromosomal Passenger Complex for Localization during Mitosis
Wilmeth, L. J., Shrestha, S., Montaño, G., Rashe, J., & Shuster, C. B. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0471 · Cited by 27
Yes-Associated Protein (Yap) Is Required for Early Embryonic Development in Zebrafish (Danio Rerio)
Hu, J., Sun, S., Qiu, J., Sun, S., Wang, W., Gui, Y., & Song, H. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.4887 · Cited by 30
“The Hpo pathway, a novel signaling pathway defined in drosophila, is extremely powerful in the regulation of growth and the suppression of tumors because of its ability to simultaneously inhibit cell proliferation and promote apoptosis [1-4].”
BackgroundThe Role of Hippo Signaling Pathway in the Development of the Nervous System
Li, X., Li, K., Chen, Y., & Fang, F. (2021) · Developmental Neuroscience · doi:10.1159/000515633 · Cited by 27
Bunched, the Drosophilahomolog of the mammalian tumor suppressor TSC-22, promotes cellular growth
Gluderer, S., Oldham, S., Rintelen, F., Sulzer, A., Schütt, C., Wu, X., Raftery, L. A., Hafen, E., & Stocker, H. (2008) · BMC Developmental Biology · doi:10.1186/1471-213x-8-10 · Cited by 25
“In addition, screens for genes restricting growth have identified the Hippo-Salvador-Warts signaling cassette that may also have a tumor suppressor function in humans [33,34].”
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling
Zhao, Y., & Yang, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4259 · Cited by 26
“TAZ is one of the core components of the Hippo pathway that is involved in various physiological and pathological activities, such as organ size control, tumorigenesis, tissue homeostasis, energy homeostasis [8–10, 30–33].”
BackgroundChung, H.-Y., Gu, M., Buehler, E. C., MacDonald, M. R., & Rice, C. M. (2014) · Journal of Virology · doi:10.1128/jvi.01582-14 · Cited by 26
Zecca, M., & Struhl, G. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001111 · Cited by 25
Dong, D.-J., Jing, Y.-P., Liu, W., Wang, J., & Zhao, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.643783 · Cited by 24
“Genetic studies in Drosophila defined a conserved Hippo signaling pathway that controls organ size by both restricting cell proliferation and promoting apoptosis (2).”
BackgroundRobinson, B. S., & Moberg, K. H. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18243 · Cited by 25
NTRK1 is a positive regulator of YAP oncogenic function
Yang, X., Shen, H., Buckley, B., Chen, Y., Yang, N., Mussell, A. L., Chernov, M., Kobzik, L., Frangou, C. G., Han, S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0609-1 · Cited by 25
Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma
Jia, M., Xiong, Y., Li, M., & Mao, Q. (2020) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504020x15853075736554 · Cited by 24
Mohammadpour, S., Esfahani, A. T., Sarpash, S., Vakili, F., Zafarjafarzadeh, N., Mashaollahi, A., Pardakhtchi, A., & Mojarad, E. N. (2024) · Analytical Cellular Pathology · doi:10.1155/2024/5767535 · Cited by 29
“Moreover, planar cell polarity (PCP), mediated by the interaction between protocadherins Fat (Ft) and Dachsous (Ds), contributes signi fi cantly to Hippo pathway regulation, with the steepness of Ds – Fj gradients dictating pathway activity [36, 37].”
BackgroundRichardson, H. E. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.174 · Cited by 23
“Over the last 10 years, the Hpo signalling pathway has emerged as a key negative regulator of tissue growth in Drosophila and mammalian systems (reviewed by Harvey and Tapon (2007)).”
BackgroundXu, F., Wang, Y., Chang, J.-J., Du, S., Diao, L., Jiang, N., Wang, H., Ma, D., & Zhang, J. (2013) · Biochemical Journal · doi:10.1042/bj20130986 · Cited by 23
hSav1 interacts with HAX1 and attenuates its anti-apoptotic effects in MCF-7 breast cancer cells
Hu, J. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.692 · Cited by 25
“…the recently described Salvador-Warts-Hippo (SWH) pathway, which includes several tumor suppressor genes, such as: fat (1,2) merlin (3), expanded, hippo (4), RASSF (5), Lats/Warts (6), Salvador (7) and an oncogene called yorkie (8-10) and controls cell growth, proliferation, and apoptosis (10).”
RASSF6; the Putative Tumor Suppressor of the RASSF Family
Iwasa, H., Jiang, X., & Hata, Y. (2015) · Cancers · doi:10.3390/cancers7040899 · Cited by 26
“As described later, Salvador and Hippo are the founding members of the tumor suppressor Hippo pathway [4,5].”
BackgroundAngiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
Zeng, H., Ortiz, A., Shen, P.-F., Cheng, C.-J., Lee, Y.-C., Yu, G., Lin, S.-C., Creighton, C. J., Yu‐Lee, L., & Lin, S.-H. (2016) · Oncotarget · doi:10.18632/oncotarget.14358 · Cited by 23
The role of inflammation in subventricular zone cancer
Bardella, C., Al‐Shammari, A. R., Soares, L. C., Tomlinson, I. P. M., O’Neill, E. E., & Szele, F. G. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.04.007 · Cited by 26
“The Hippo tumor suppressor pathway is important for normal tissue growth and homeostasis and is a key signalling pathway that maintains cell polarity (Harvey and Tapon, 2007).”
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma
Hellwig, M., Lauffer, M. C., Bockmayr, M. L., Spohn, M., Merk, D. J., Harrison, L., Ahlfeld, J., Kitowski, A., Neumann, J. E., Ohli, J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01982-5 · Cited by 25
How size is controlled: from Hippos to Yorkies
Buttitta, L., & Edgar, B. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1107-1225 · Cited by 23
Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1
Zhang, X., Guo, C., Wu, X., Li, A. X., Liu, L., Tsark, W. M. K., Dammann, R., Shen, H., Vonderfecht, S. L., & Pfeifer, G. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3010 · Cited by 22
“MST1/MST2 kinases activate two downstream kinases, LATS1 and LATS2 (14).”
InfluentialSong, W., Zhang, J., Zhang, J., Sun, M., & Xia, Q. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0857-3 · Cited by 22
RetractedBarbosa, I. A. M., Gopalakrishnan, R., Mercan, S., Mourikis, T. P., Martin, T., Wengert, S., Sheng, C., Ji, F., Lopes, R., Knehr, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39527-w · Cited by 25
Chen, J., Chen, H., Dong, X., Hui, T., Yan, M., Ren, D., Zou, S., Wang, S., Fei, E., Zhang, W., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06581-1 · Cited by 25
Xia, D., Li, X., Niu, Q., Liu, X.-S., Xu, W., Ma, C., Gu, H., Liu, Z., Shi, L., Tian, X., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5447 · Cited by 22
“The hippo signaling pathway, first identified in the 1990s through genetic screens in overgrown Drosophila, is a conserved signaling pathway that serves essential roles in the regulation of organ growth, stem cell function, regeneration and tumor suppression (30,31).”
Hypermethylation of MST1 in IgG4-related autoimmune pancreatitis and rheumatoid arthritis
Fukuhara, T., Tomiyama, T., Yasuda, K., Ueda, Y., Ozaki, Y., Son, Y., Nomura, S., Uchida, K., Okazaki, K., & Kinashi, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.043 · Cited by 22
“[3] K. Katagiri, A. Maeda, M. Shimonaka, et al., RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1, Nat Immunol 4 (2003) 741-748.”
BackgroundContext-Dependent Requirement for dE2F during Oncogenic Proliferation
Nicolay, B., & Frolov, M. V. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000205 · Cited by 22
“Overexpression of yki or inactivation of negative regulators of the Hippo tumor suppressor pathway, such as wts, renders cells of the eye imaginal disc refractory to the cell cycle exit signals and, as a result, cells continue to proliferate inappropriately [19,21].”
BackgroundCe‐wts‐1 plays important roles in Caenorhabditis elegans development
Cai, Q., Wang, W., Gao, Y. D., Yang, Y., Zhu, Z., & Fan, Q. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.09.002 · Cited by 25
“A lack of these tumor suppressors leads to overgrowth in a variety of tissues in Drosophila melanogaster, while a gain-of-function leads to reduced proliferation and ectopic apoptosis [3].”
BackgroundImmunometabolic regulation during the presence of microorganisms and parasitoids in insects
Li, S., Wang, J., Tian, X., Toufeeq, S., & Huang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.905467 · Cited by 32
Demircan, T., & Berezikov, E. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0006 · Cited by 30
“The Hippo pathway core genes ( Hpo , Sav , Wts , and Mats ) are broadly expressed in both proliferating and differentiated cells.”
InfluentialZhang, J., Yao, S., Hu, Q., Zhu, Q., Liu, S., Lunetta, K. L., Haddad, S. A., Yang, N., Shen, H., Hong, C., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw077 · Cited by 24
Developmental control of cell growth and division in Drosophila
Thompson, B. J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.018 · Cited by 27
Metadata
- Authors
- Harvey, K., & Tapon, N.
- Affiliations
- Peter MacCallum Cancer Centre (AU)
- Cancer Research UK (GB)
- Corresponding author
- Harvey, Kieran
- Venue
- Nature Reviews Cancer
- Published
- 2007-03
- Volume
- 7
- Issue
- 3
- Pages
- 182-191
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1567765448
- Cited by
- 628
- References
- 99
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 21 · 2023: 9 · 2022: 25 · 2021: 19 · 2020: 32 · 2019: 31 · 2018: 36 · 2017: 30 · 2016: 45 · 2015: 36 · 2014: 31 · 2013: 55 · 2012: 50
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- tumor suppression, tissue growth control, Drosophila melanogaster, carcinogenesis, evolutionary conservation, signaling networks, human cancer
- MeSH terms
- Hippo Kinases, Animals, Humans, Protein Kinases, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Drosophila Proteins, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.